195 related articles for article (PubMed ID: 15853595)
1. Iloprost for idiopathic pulmonary arterial hypertension.
Leuchte HH; Behr J
Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):215-23. PubMed ID: 15853595
[TBL] [Abstract][Full Text] [Related]
2. Inhaled iloprost in pulmonary arterial hypertension.
Baker SE; Hockman RH
Ann Pharmacother; 2005; 39(7-8):1265-74. PubMed ID: 15976392
[TBL] [Abstract][Full Text] [Related]
3. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
[TBL] [Abstract][Full Text] [Related]
4. Inhaled iloprost as a long-term additional therapy to oral sildenafil in severe idiopathic pulmonary arterial hypertension.
Onen ZP; Akkoca Yildiz O; Eriş Gülbay B; Karabiyikoğlu G
Tuberk Toraks; 2006; 54(2):177-81. PubMed ID: 16924576
[TBL] [Abstract][Full Text] [Related]
5. Survival of patients with idiopathic pulmonary arterial hypertension after listing for transplantation: impact of iloprost and bosentan treatment.
Dandel M; Lehmkuhl HB; Mulahasanovic S; Weng Y; Kemper D; Grauhan O; Knosalla C; Hetzer R
J Heart Lung Transplant; 2007 Sep; 26(9):898-906. PubMed ID: 17845928
[TBL] [Abstract][Full Text] [Related]
6. Inhalative iloprost - pharmacology and clinical application.
Ewert R; Schäper C; Halank M; Gläser S; Opitz CF
Expert Opin Pharmacother; 2009 Sep; 10(13):2195-207. PubMed ID: 19663611
[TBL] [Abstract][Full Text] [Related]
7. Prostacyclin therapy for pulmonary arterial hypertension: new directions.
Gomberg-Maitland M; Preston IR
Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316
[TBL] [Abstract][Full Text] [Related]
8. Long-term inhaled iloprost use in children with pulmonary arterial hypertension.
Alehan D; Yıldırım I; Sahin M; Ozkutlu S; Ozer S; Karagöz T
Cardiol Young; 2012 Aug; 22(4):396-403. PubMed ID: 22067137
[TBL] [Abstract][Full Text] [Related]
9. [Aerosolized iloprost combined with a phosphodiesterase inhibitor in the treatment of primary pulmonary hypertension].
Isa R; Castro P; Martínez A
Rev Med Chil; 2004 Mar; 132(3):353-6. PubMed ID: 15376573
[TBL] [Abstract][Full Text] [Related]
10. Iloprost for chronic thromboembolic pulmonary hypertension.
Roig Figueroa V; Herrero Pérez A; de la Torre Ferrera N; Hernández García E; Aller Alvarez JL; Para Cabello J
Arch Bronconeumol; 2004 Jul; 40(7):326-8. PubMed ID: 15225519
[TBL] [Abstract][Full Text] [Related]
11. [Sildenafil for treatment of severe pulmonary hypertension and commencing right-heart failure].
Ghofrani HA; Olschewski H; Seeger W; Grimminger F
Pneumologie; 2002 Nov; 56(11):665-72. PubMed ID: 12442206
[TBL] [Abstract][Full Text] [Related]
12. Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension.
Hoeper MM; Leuchte H; Halank M; Wilkens H; Meyer FJ; Seyfarth HJ; Wensel R; Ripken F; Bremer H; Kluge S; Hoeffken G; Behr J
Eur Respir J; 2006 Oct; 28(4):691-4. PubMed ID: 17012628
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological treatment of pulmonary arterial hypertension].
Pulido Zamudio T
Arch Cardiol Mex; 2007; 77 Suppl 4():S4-198-201. PubMed ID: 18938726
[TBL] [Abstract][Full Text] [Related]
14. [Emerging therapies for the treatment of pulmonary arterial hypertension].
Ghofrani HA; Voswinckel R; Reichenberger F; Grimminger F; Seeger W
Herz; 2005 Jun; 30(4):296-302. PubMed ID: 15965806
[TBL] [Abstract][Full Text] [Related]
15. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension.
Krug S; Hammerschmidt S; Pankau H; Wirtz H; Seyfarth HJ
Respiration; 2008; 76(2):154-9. PubMed ID: 17804899
[TBL] [Abstract][Full Text] [Related]
16. Treatments for pulmonary arterial hypertension.
Liu C; Liu K; Ji Z; Liu G
Respir Med; 2006 May; 100(5):765-74. PubMed ID: 16549344
[TBL] [Abstract][Full Text] [Related]
17. Iloprost inhalation solution for the treatment of pulmonary arterial hypertension.
Hsu HH; Rubin LJ
Expert Opin Pharmacother; 2005 Sep; 6(11):1921-30. PubMed ID: 16144511
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology and efficacy of inhaled iloprost for the treatment of pulmonary arterial hypertension.
John J; Palevsky H
Expert Rev Clin Pharmacol; 2011 Mar; 4(2):197-205. PubMed ID: 22115402
[TBL] [Abstract][Full Text] [Related]
19. Role of iloprost and bosentan in pulmonary arterial hypertension.
Saleh JA
Niger J Med; 2008; 17(1):13-9. PubMed ID: 18390125
[TBL] [Abstract][Full Text] [Related]
20. Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension.
Lai YJ; Pullamsetti SS; Dony E; Weissmann N; Butrous G; Banat GA; Ghofrani HA; Seeger W; Grimminger F; Schermuly RT
Am J Respir Crit Care Med; 2008 Jul; 178(2):188-96. PubMed ID: 18467507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
